2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference to Webcast Millennium Presentation

Search Blogs that Mention this News Release

Click this link to view linked Bookmarking Services

Click this link to view linked Blogging Services

2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference to Webcast Millennium Presentation

		Millennium Pharmaceuticals, Inc. Logo. (PRNewsFoto/Millennium Pharmaceuticals, Inc.) CAMBRIDGE, MA UNITED STATES

    CAMBRIDGE, Mass., Jan. 31 /PRNewswire-FirstCall/ -- Millennium
Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that its presentation
at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical
Device Conference will be webcast live and may be accessed by visiting the
Investors section of the Company's website, http://www.millennium.com.

    (Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

    During the presentation, Dr. Deborah Dunsire, president and chief
executive officer, and Marsha Fanucci, chief financial officer and senior
vice president, corporate strategy, will discuss the Company's 2007
financial results as well as goals and financial guidance for 2008. The
presentation will be delivered at 8:00 a.m. ET on Thursday, February 7,
2008 from The Grand Hyatt Hotel in New York, NY. The presentation will be
archived for 30 days.

    Before the presentation on February 7, 2008, the Company's 2007
year-end financial results will be issued in a press release.

    About Millennium

    Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company
based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a
novel cancer product, and has a robust clinical development pipeline of
product candidates. The Company's research, development and
commercialization activities are focused in two therapeutic areas: oncology
and inflammation. By applying its knowledge of the human genome,
understanding of disease mechanisms and industrialized drug discovery
platform, Millennium is developing an exciting pipeline of innovative
product candidates. The Company's website is http://www.millennium.com.

    Editors' Note: This press release is also available under the Media
section of the Company's website at: http://www.millennium.com.

    Contact:

    Kyle Kuvalanka

    (617) 761-4734

SOURCE Millennium Pharmaceuticals, Inc.

http://www.millennium.com
Photo Notes:
NewsCom: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com

http://www.prnewswire.com/comp/114562.html/
CONTACT:
Kyle Kuvalanka of Millennium Pharmaceuticals,
Inc., +1-617-761-4734